Accelerate Diagnostics
AXDX
$0.95
Share price
1.54%
Change (1 day)
5.03%
Change (1 year)
Categories
Accelerate Diagnostics (AXDX) - Net assets
Net assets on the balance sheet as of September 2023 : -$35.04 M
According to Accelerate Diagnostics's latest financial reports the company has -$35.04 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Accelerate Diagnostics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $-22.27 M | -36.52% |
| 2021-12-31 | $-35.08 M | -44.17% |
| 2020-12-31 | $-62.82 M | 751.23% |
| 2019-12-31 | $-7.38 M | -112.86% |
| 2018-12-31 | $57.37 M | -51.67% |
| 2017-12-31 | $0.11 B | 52.54% |
| 2016-12-31 | $77.81 M | -41.5% |
| 2015-12-31 | $0.13 B | 101.57% |
| 2014-12-31 | $65.99 M | 58.95% |
| 2013-12-31 | $41.51 M | |
| 2012-07-31 | $14.83 M | 208.08% |
| 2011-07-31 | $4.81 M | -1.92% |
| 2010-07-31 | $4.9 M | 26.07% |
| 2009-07-31 | $3.89 M | -11.75% |
| 2008-07-31 | $4.41 M | -9.57% |
| 2007-07-31 | $4.88 M | -27.59% |
| 2006-07-31 | $6.73 M | -30.29% |
| 2005-07-31 | $9.66 M | -17.62% |
| 2004-07-31 | $11.73 M | -7.8% |
| 2003-07-31 | $12.72 M | -7.39% |
| 2002-07-31 | $13.74 M | 43% |
| 2001-07-31 | $9.61 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $46.84 B | -133,808.22% | 🇺🇸 USA |
 Becton Dickinson BDX | $25.33 B | -72,411.82% | 🇺🇸 USA |
 PerkinElmer
PKI | $8.03 B | -23,032.12% | 🇺🇸 USA |
 Bruker BRKR | $1.41 B | -4,134.20% | 🇺🇸 USA |
 NanoString Technologies NSTG | -$50.57 M | 44.34% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $8.74 B | -25,051.13% | 🇺🇸 USA |